- Research works
- 34 ▲ 54% vs 2013–17
- Citations
- 256 7.6 per fractional work
- Top-10% rate
- 12.0% record average 16.5%
- Open access
- 37% world 28%
Not ranked overall: Yuhan (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.8×. Every wedge is a field page.
Which keywords describe research at Yuhan (South Korea)?
By fractional works in all years, weighted toward what it does more of than the world: Metabolism, Inflammation, Cancer Immunotherapy, Glycosylation, Cancer, Monoclonal Antibodies, Fc Receptors and Therapeutic Antibodies.
- landscape conservation
- Privacy Concerns
- Neuroprotection
- Trust
- Obesity
- Chemotherapy
- Chimeric Antigen Receptor
- Therapeutic Antibodies
- Immunotherapy
- Glycosylation
- Sustainability
- Metabolism
- Inflammation
- Cancer
- Cancer Immunotherapy
- Fc Receptors
- Monoclonal Antibodies
- CAR T Cells
- Signaling
- Machine Learning
- PI3K/AKT pathway
- mTOR
- Online Social Networks
- Satoyama
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Inflammation3▲ 4.0×17 topics
- Metabolism2▲ 11×6 topics
- Cancer2▲ 4.0×8 topics
- Sustainability2▲ 3.2×4 topics
- Cancer Immunotherapy2▲ 38×2 topics
- Glycosylation2▲ 20×2 topics
- Fc Receptors1▲ 40×1 topic
- Immunotherapy1▲ 6.2×3 topics
- Monoclonal Antibodies1▲ 29×2 topics
- Therapeutic Antibodies1▲ 31×1 topic
- CAR T Cells1▲ 80×1 topic
- Chimeric Antigen Receptor1▲ 80×1 topic
- Signaling1▲ 32×3 topics
- Chemotherapy1▲ 4.5×6 topics
- Machine Learning1▲ 1.51×5 topics
- Obesity1▲ 4.4×3 topics
- PI3K/AKT pathway1▲ 147×1 topic
- Trust1▲ 12×2 topics
- mTOR1▲ 147×1 topic
- Neuroprotection1▲ 7.9×2 topics
- Online Social Networks1▲ 128×1 topic
- Privacy Concerns1▲ 68×1 topic
- Satoyama1▲ 169×1 topic
- landscape conservation1▲ 169×1 topic
Which research topics does Yuhan (South Korea) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, HER2/EGFR in Cancer Research and Sentiment Analysis and Opinion Mining.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 HER2/EGFR in Cancer Research Oncology 0 works
- 4 Sentiment Analysis and Opinion Mining Artificial Intelligence 0 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 6 Advanced Text Analysis Techniques Artificial Intelligence 0 works
- 7 Immunotherapy and Immune Responses Immunology 0 works
- 8 AI in Service Interactions Artificial Intelligence 0 works
- 9 Rural development and sustainability General Agricultural and Biological Sciences 0 works
- 10 Immune cells in cancer Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Yuhan (South Korea)'s research output changed?
Output in 2018–2022 was 54% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seoul
- Seoul National University
- Yonsei University
- Korea University
- Sungkyunkwan University
- Hanyang University
- Kyung Hee University
- Chung-Ang University
- Samsung (South Korea)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.